A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Tetrazole as a Replacement of the Electrophilic Group in Characteristic Prolyl Oligopeptidase Inhibitors




TekijätKilpelainen TP, Tyni JK, Lahtela-Kakkonen MK, Etelainen TS, Myohanen TT, Wallen EAA

KustantajaAMER CHEMICAL SOC

Julkaisuvuosi2019

Lehti: ACS Medicinal Chemistry Letters

Tietokannassa oleva lehden nimiACS MEDICINAL CHEMISTRY LETTERS

Lehden akronyymiACS MED CHEM LETT

Vuosikerta10

Numero12

Aloitussivu1635

Lopetussivu1640

Sivujen määrä11

ISSN1948-5875

DOIhttps://doi.org/10.1021/acsmedchemlett.9b00394


Tiivistelmä
4-Phenylbutanoyl-aminoacyl-2(S)-tetrazolylpyrrolidines were studied as prolyl oligopeptidase inhibitors. The compounds were more potent than expected from the assumption that the tetrazole would also here be a bioisostere of the carboxylic acid group and the corresponding carboxylic acids are at their best only weak inhibitors. The aminoacyl groups L-prolyl and L-alanyl gave potent inhibitors with IC50 values of 12 and 129 nM, respectively. This was in line with typical prolyl oligopeptidase inhibitors; however, we did observe a difference with N-methyl-L-alanyl, which gave potent inhibitors in typical prolyl oligopeptidase inhibitors but not in our novel compound series. Furthermore, all studied 4-phenylbutanoyl-aminoacyl-2(S)-tetrazolylpyrrolidines decreased alpha-synuclein dimerization at the concentration of 10 mu M, also when they were only weak inhibitors of the proteolytic activity of the enzyme with an IC50 value of 205 mu M. Molecular docking studies revealed that the compounds are likely to bind differently to the enzyme compared to typical prolyl oligopeptidase inhibitors represented in this study by 4-phenylbutanoyl-aminoacyl-2(S)-cyanopyrrolidines.



Last updated on